Navigation Links
DiagnoCure signs distribution agreement in the UK for its colorectal cancer test
Date:10/5/2009

Ticker Symbol: CUR

QUEBEC CITY, Oct. 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that it signed an exclusive agreement with a new partner, Lab21, a global provider of diagnostic products and services, for the promotion, marketing and selling of its Previstage(TM) GCC Colorectal Cancer Staging Test in the United Kingdom and Ireland. Lab21 will offer the Previstage(TM) GCC test as part of its oncology testing services, and patient samples will be processed in DiagnoCure's U.S. clinical laboratory.

"This new partnership is a key initial step in reaching out to the European market. Lab21 is a leading provider of state-of-the-art diagnostics and world class customer service. This new avenue will support the global growth for our Previstage(TM) GCC Colorectal Cancer Staging Test," stated John C. Schafer, President and CEO of DiagnoCure.

Terms of the agreement were not disclosed.

Each year, 36,400 people are diagnosed with colorectal cancer in the U.K. Of that number, about 9,600 will be considered free of metastases (stage I or II) following the surgery and may benefit from the more accurate staging offered by Previstage(TM) GCC.

Presentation at BioContact

On October 7th, John C. Schafer, President and CEO of DiagnoCure, will present an update of the Company's activities at BioContact 2009, a biopharmaceutical partnership symposium, held in Quebec City.

About DiagnoCure

DiagnoCure (TSX: CUR) is a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services that increase clinician and patient confidence in making critical treatment decisions. DiagnoCure Oncology Laboratories, a subsidiary of DiagnoCure Inc., launched in 2008 the Previstage(TM) GCC Colorectal Cancer Staging Test, the first GCC-ba
'/>"/>

SOURCE DiagnoCure Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DiagnoCure to host Q2 2009 earnings conference call and webcast
2. DiagnoCure announces first quarter 2009 results
3. New website empowers colorectal cancer patients when discussing critical treatment decisions - DiagnoCure launches www.mypersonalcancerdiagnosis.com
4. DiagnoCure to Host Q1 2009 Earnings Conference Call and Webcast
5. Major study on DiagnoCures GCC biomarker published in Jama
6. DiagnoCure announces fourth quarter 2008 and year-end results
7. DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast
8. DiagnoCure to webcast presentation at the Piper Jaffray Health Care Conference on December 3, 2008
9. DiagnoCure to present at the JMP Securities Healthcare Focus Conference on October 6, 2008
10. Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test
11. DiagnoCures GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... Updated enrollment data on the ... team, can now be accessed at http://www.AISHealth.com . The data is free to ... Plans: 2015, the tables and charts on the website’s “Data” section include:, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Rock Your ... Pop & Rock Beauty Bash Tour. In addition, they have signed Lexi Noel, dubbed ... will appear in forthcoming print and overall branding opportunities for the company. , ...
(Date:8/4/2015)... New York, NY (PRWEB) , ... August 04, 2015 , ... ... is all but universal, though the desire for invasive surgery to achieve this ideal ... can offer the results people crave without the high cost or lengthy recovery time, ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... awarded independent educational grants in support of an interaction simulation session entitled "NOACS: ... activity is jointly provided by Medical Learning Institute Inc. and EDUmotion US LLC. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Following last month’s successful rollout of its ... Cath Lab Accreditation in an Academic Setting, and The Importance of PVI Accreditation. , ... taped during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 3
... SPRINGS, Fla., Jan. 31 Tigris Pharmaceuticals,Inc., a privately ... of Mr. Pedro Granadillo to its Board of Directors., ... Eli Lilly and,Company ("Lilly") until 2004 when he retired ... Policy Committee, which was comprised of its top,seven executives. ...
... ... Rebranding, COLUMBIA, S.C., Jan. ... involves the sole sponsorship for the,"One-on- One" match-up analysis to run ... remainder of the regular NCAA season., (Logo: http://www.newscom.com/cgi-bin/prnh/20080109/CLW033LOGO ...
... Guidance -, BRAINTREE, Mass., Jan. 31 Haemonetics,Corporation ... 2008 GAAP net,revenues of $135 million, up 18.6%; net ... share of $0.54, down 12.1%., Third quarter fiscal ... and 2008 and certain tax benefits in 2007, was ...
... took the B vitamin for one year before conception, study ... to help prevent birth defects, folic acid may also help ... study that included almost 40,000 women, a team of U.S. ... supplements for a year or longer before conception had a ...
... Strong International Performance and InLight ... Equipment Sales, GLENWOOD, ... and environmental radiation,monitoring, today reported record performance in its first fiscal quarter,ended ... Revenue reached a record $21.8 million on higher international revenues ...
... /PRNewswire-FirstCall/ - DRAXIS Health Inc. (TSX:,DAX) (Nasdaq: DRAX ... Quarter and Year End 2007 on Thursday February 7, ... audio webcast at 10:00 a.m.,(ET) to discuss the results ... the conference call and webcast are as follows:, ...
Cached Medicine News:Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 3Health News:Colonial Life Goes 'One On One' With ESPN 2Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 2Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 3Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 4Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 5Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 6Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 7Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 8Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 9Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 10Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 11Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 12Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 13Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 14Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 15Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 16Health News:Folic Acid May Help Prevent Premature Birth 2Health News:Folic Acid May Help Prevent Premature Birth 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 2Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 4Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 5Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 6Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 7Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 2Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 3Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 4
(Date:8/4/2015)... ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ... six months ended June 30, 2015 and updated its ... earnings conference call this morning, August 4, 2015, at ... join the call by dialing (855) 582-8078. The conference ... , Year-to-date net revenues of $38.3 million, an increase of ...
(Date:8/4/2015)... , Aug. 4, 2015  Ironshore Pharmaceuticals & ... Restore Health, a company specializing in personalized medicine, ... clinical trial, designed to evaluate the safety and ... to treat Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s ... Restore Health originally partnered with Ironshore in 2014 ...
(Date:8/3/2015)... WEST JORDAN, Utah , Aug. 3, 2015  BC ... Solutions has acquired Ohio Valley Medical Systems, one of ... MRI systems.  The addition of Ohio Valley Medical Systems ... to now include Hitachi MRI.   "We ... Mark Alvarez , President and CEO of BC Technical. ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2BC Technical Acquires Ohio Valley Medical Systems 2
... Clinical Trial to be Presented at Retrovirus ConferenceLEXINGTON, Mass., ... IDEV ) announced today that a National Institutes of ... received PRO 2000, the Company,s candidate vaginal microbicide for ... acquiring HIV infection than women who received a placebo ...
... The U.S. Agency for International Development (USAID) continues to ... in the midst of an expanding humanitarian crisis. An ... left the people of Zimbabwe in danger of other ... is supporting emergency Indoor Residual Spraying (IRS) to shore ...
Cached Medicine Technology:Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 2Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 3Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 4Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 5Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study 6USAID Provides Malaria Assistance to Zimbabwe 2
... T is a quadripolar pacing ... pacing and monitoring during and ... 227 T features tines for ... allows safe and easy implantation ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: